Besilesomab
Besilesomab
Besilesomab (pronunciation: be-si-le-so-mab) is a monoclonal antibody used in the detection of infection and inflammation.
Etymology
The term "Besilesomab" is derived from the following components: "Be" for Beringwerke (the manufacturer), "si" for infection/inflammation, "le" for mouse (from the Latin 'lego' meaning 'I choose'), and "somab" for monoclonal antibody.
Usage
Besilesomab is used in the detection of infection and inflammation. It is a monoclonal antibody that is radiolabelled with Technetium-99m. The antibody targets the granulocyte receptor, which is present in high numbers in areas of infection and inflammation.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Infection: The invasion of body tissues by disease-causing agents, their multiplication, and the reaction of body tissues to these agents and the toxins they produce.
- Inflammation: A localized physical condition in which part of the body becomes reddened, swollen, hot, and often painful, especially as a reaction to injury or infection.
- Granulocyte: A type of white blood cell that has small granules, which contain proteins. The specific types of granulocytes are neutrophils, eosinophils, and basophils.
External links
- Medical encyclopedia article on Besilesomab
- Wikipedia's article - Besilesomab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski